AVTR vs AZTA
AVTR: Global provider of mission-critical laboratory consumables, specialty chemicals, and biopharmaceutical manufacturing solutions serving life sciences, healthcare, and advanced technology markets worldwide. AZTA: Azenta is a provider of life sciences solutions focused on automated sample management and genomic services for research and clinical development.
Side-by-side fundamentals
| Metric | AVTR | AZTA | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $10.95 | $27.16 | |
| Market cap as of 2026-07-23 | $7.5B | $1.2B | |
| PEG as of 2026-07-23 | n/a | -0.04 | |
| Net margin as of 2026-07-23 | -8.4% | -29.9% | AVTR higher |
| Gross margin as of 2026-07-23 | +32.1% | +43.9% | AZTA higher |
| Operating margin as of 2026-07-23 | -4.6% | -28.9% | AVTR higher |
| ROE as of 2026-07-23 | -9.6% | -10.7% | AVTR higher |
| ROA as of 2026-07-23 | -4.6% | -8.8% | AVTR higher |
| Debt / equity as of 2026-07-23 | 0.68 | 0.00 | AZTA lower |
| Revenue growth (YoY) as of 2026-07-23 | -2.0% | -5.9% | AVTR higher |
| Revenue CAGR (3y) SEC XBRL | -4.5% | +2.2% | AZTA higher |
| Dividend streak (yrs) SEC XBRL | n/a | 1 | |
| Beta as of 2026-07-23 | 0.92 | 1.39 | |
| 1-year return as of 2026-07-22 close | -10.9% | -15.1% | AVTR higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.